<p>Dendreon, a pioneer in the cell therapy space through its commercial product Provenge, has relaunched itself as a contract development and manufacturing organization (CDMO).</p>
<p>BioProcess Insider speaks with Maria Cho, the VP of Business Development and Corporate Strategy, about Dendreon's strategic growth efforts in the cellular immunotherapy space and how it is embracing its proven success in the field to support others.</p>

Dendreon, a pioneer in the cell therapy space through its commercial product Provenge, has relaunched itself as a contract development and manufacturing organization (CDMO). BioProcess Insider speaks with Maria Cho, the VP of Business Development and Corporate Strategy, about Dendreon's strategic growth efforts in the cellular immunotherapy space and how it is embracing its proven success in the field to support others.

Dendreon‘s leap into the cell therapy CDMO space

From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head.

www.bioprocessinsider.com

Business

Science

Life Sciences

From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head. www.bioprocessinsider.com

Share Dendreon‘s leap into the cell therapy CDMO space

Sign up to save your podcasts

Dendreon‘s leap into the cell therapy CDMO space

Dendreon‘s leap into the cell therapy CDMO space